Tango Therapeutics executive chair Barbara Weber steps down, exits board
TNGX•Executive chair departure
Tango Therapeutics said Executive Chair Barbara Weber’s employment ended on Aug. 3, 2026.
Weber is deemed to have resigned from all officer roles and her board seat upon termination.
The filing said her departure was not tied to any disagreement over the company’s operations, practices, or policies.
